NEPHROS, INC. Long-Term Debt, Maturity, Year Five
NEPHROS, INC. (NEPH) had Long-Term Debt, Maturity, Year Five of $71.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2019-11-06
- 2019-09-30: Long-Term Debt, Maturity, Year Five $71.00K.
- 2018-12-31: Long-Term Debt, Maturity, Year Five $95.00K.
- 2018-09-30: Long-Term Debt, Maturity, Year Five $71.00K.
- 2018-06-30: Long-Term Debt, Maturity, Year Five $71.00K.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2019-09-30 | $71.00K 10-Q · filed 2019-11-06 |
| 2018-12-31 | $95.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $71.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $71.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |